Following the release of trial data, the FDA has approved erdafitinib for the treatment of adult patients with fibroblast growth…

Completed by a total of 3,981 cancer patients across 10 countries, All.Can is the biggest survey of its kind aiming…

Bevacizumab-bvzr (Zirabev; Pfizer), a biosimilar to bevacizumab (Avastin; Genentech) has been given the go-ahead by the FDA for five indications….

Are you ready for ESMO 2017? The Video Journal of Oncology is excited to be attending the ESMO 2017 Congress…

It has been known for almost a century that thoracic radiotherapy can cause damage to the heart.[2] However, the first…

The American Society of Hematology (ASH) Annual Congress dedicated a special-interest session on social media in 2016, called ‘Social Media…

At the European Cancer Congress 2017 in Amsterdam, the European Cancer Patient Coalition launched a new white paper on the…